Document Detail


Murine microenvironment metaprofiles associate with human cancer etiology and intrinsic subtypes.
MedLine Citation:
PMID:  23339125     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: Ionizing radiation is a well-established carcinogen in rodent models and a risk factor associated with human cancer. We developed a mouse model that captures radiation effects on host biology by transplanting unirradiated Trp53-null mammary tissue to sham or irradiated hosts. Gene expression profiles of tumors that arose in irradiated mice are distinct from those that arose in naïve hosts. We asked whether expression metaprofiles could discern radiation-preceded human cancer or be informative in sporadic breast cancers.
EXPERIMENTAL DESIGN: Affymetrix microarray gene expression data from 56 Trp53-null mammary tumors were used to define gene profiles and a centroid that discriminates tumors arising in irradiated hosts. These were applied to publicly available human cancer datasets.
RESULTS: Host irradiation induces a metaprofile consisting of gene modules representing stem cells, cell motility, macrophages, and autophagy. Human orthologs of the host irradiation metaprofile discriminated between radiation-preceded and sporadic human thyroid cancers. An irradiated host centroid was strongly associated with estrogen receptor-negative breast cancer. When applied to sporadic human breast cancers, the irradiated host metaprofile strongly associated with basal-like and claudin-low breast cancer intrinsic subtypes. Comparing host irradiation in the context of TGF-β levels showed that inflammation was robustly associated with claudin-low tumors.
CONCLUSIONS: Detection of radiation-preceded human cancer by the irradiated host metaprofile raises possibilities of assessing human cancer etiology. Moreover, the association of the irradiated host metaprofiles with estrogen receptor-negative status and claudin-low subtype suggests that host processes similar to those induced by radiation underlie sporadic cancers.
Authors:
David H Nguyen; Erik Fredlund; Wei Zhao; Charles M Perou; Allan Balmain; Jian-Hua Mao; Mary Helen Barcellos-Hoff
Related Documents :
24275135 - Recommendations for breast cancer surveillance for female survivors of childhood, adole...
15189955 - Seeking a home for a pet, part 2: defining the appropriate place for positron emission ...
19081855 - Highlights and prizes of an international meeting.
24297455 - Multilevel factors associated with overall mortality for men diagnosed with prostate ca...
21843415 - Physician visits and colorectal cancer testing among medicare enrollees in north caroli...
22968065 - Surgeon knowledge contributes to the relationship between surgeon volume and patient ou...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.     Date:  2013-01-21
Journal Detail:
Title:  Clinical cancer research : an official journal of the American Association for Cancer Research     Volume:  19     ISSN:  1078-0432     ISO Abbreviation:  Clin. Cancer Res.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-03-18     Completed Date:  2013-09-23     Revised Date:  2014-03-26    
Medline Journal Info:
Nlm Unique ID:  9502500     Medline TA:  Clin Cancer Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1353-62     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Breast Neoplasms / etiology,  genetics*,  pathology
Female
Gene Expression Regulation, Neoplastic / radiation effects*
Humans
Mammary Neoplasms, Animal / etiology,  genetics*,  pathology
Mice
Radiation, Ionizing
Transcriptome / radiation effects
Tumor Microenvironment / genetics,  radiation effects
Tumor Suppressor Protein p53 / genetics*,  metabolism
Grant Support
ID/Acronym/Agency:
P50 CA058223/CA/NCI NIH HHS; P50-CA58223/CA/NCI NIH HHS; R01 CA101227/CA/NCI NIH HHS; R01-CA138255/CA/NCI NIH HHS; R01-CA148761/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Tumor Suppressor Protein p53
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metast...
Next Document:  Diffuse large B-cell lymphoma in the elderly: a review of potential difficulties.